Acetylsalicylic acid and other salicylates in relation to Stevens-Johnson syndrome and toxic epidermal necrolysis

British Journal of Clinical Pharmacology

Volumn 51, Issue 2, 2001, Pages 174-176

  Kaufman, David W ^a   Kelly, Judith P ^b   Roujeau, J C ^c   Bastuji Garin, S ^c   Baur, S ^d   Schroder W ^d   Mockenhaupt, M ^d   Schopf E ^d   Naldi, L ^e   Locati, F ^e   Correia, O ^a   Anderson, T ^f   Kaufman, D W ^f   Kelly, J P ^f   Shapiro, S ^f   Stern, R ^g   Rzany, B ^h   Auquier, A ⁱ   Paoletti, C ⁱ   Shear, N ^a  

^a BOSTON UNIVERSITY   (United States)

^b UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^c UNIVERSITY OF FREIBURG   (Germany)

^d UNIVERSITY OF MILAN   (Italy)

^e PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^f HARVARD MEDICAL SCHOOL   (United States)

^g MEDICAL FACULTY MANNHEIM HEIDELBERG UNIVERSITY   (Germany)

^h INSTITUT GUSTAVE ROUSSY   (France)

ⁱ SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

Acetylsalicylic acid; Stevens Johnson syndrome; Toxic epidermal necrolysis

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; SALICYLIC ACID DERIVATIVE;

ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DRUG FORMULATION; DRUG MIXTURE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CASE-CONTROL STUDIES; EPIDERMAL NECROLYSIS, TOXIC; HUMANS; MULTIVARIATE ANALYSIS; SALICYLATES; STEVENS-JOHNSON SYNDROME;

EID: 0035099873     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.2001.01323.x     Document Type: Article

References (5)

1. Severe adverse cutaneous reactions to drugs
2. An international collaborative case-control study of severe cutaneous adverse reactions (SCAR): Design and methods
3. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis
4. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme